- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: November 2014
- Public Summary Document (PSD) November 2014 PBAC Meeting - PDF
- Public Summary Document (PSD) November 2014 PBAC Meeting - Word
Adalimumab – November 2014
Adalimumab; 20 mg/0.4 ml injection, Humira®
Last updated
6 March 2015